314: High Risk Groups in the Tacrolimus in Combination, Tacrolimus Alone Compared (TICTAC) Trial: Evaluation of Allograft Rejection and Survival

Autor:	Margarita Camacho, H. Castillo, A. Patil, V. Hou, L. McBride, M.G. SanAugustin, Mark J. Zucker, J. Prevost-Fernandez, J. Ebuenga, D. Blicharz, S. Pardi, Alan Gass, M. Binetti, Candace Carr, A. Martin, David A. Baran, A. Pillai
Rok vydání:	2009
Předmět:	Pulmonary and Respiratory Medicine Transplantation medicine.medical_specialty Risk groups Allograft rejection business.industry Urology Medicine Surgery Cardiology and Cardiovascular Medicine business Tacrolimus
Zdroj:	The Journal of Heart and Lung Transplantation. 28:S175
ISSN:	1053-2498
DOI:	10.1016/j.healun.2008.11.321
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::175a05a80696d1cfd6ee784713a7ee0f https://doi.org/10.1016/j.healun.2008.11.321 Zobrazit plný text záznamu